Pharmability AB
PrivateLast Round
Early Funding
Apr 9, 2025
Total Funding Raised
$5.66M
Company Overview
Pharmability AB is a biotechnology company developing next-generation immunomodulatory therapies for autoimmune skin diseases, with an initial focus on atopic dermatitis.
Sector
Healthcare & Life Sciences
Verticals
Compliance & Risk, Quality Management, Biotechnology, Medical Devices, RegTech
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharmability AB Comparables
Compare Pharmability AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RegSmart Life Science AB | 87% | |
| Cencora | 77% | |
| LINK Medical | 72% |
Pharmability AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 9, 2025 | ||||
| Grant | Aug 1, 2024 | ||||
| Early Funding | Nov 20, 2020 |
Key People
Founding team and executive leadership
Pharmability AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Almi Invest AB | Early Funding |
| Vinnova | Grant |
| Sciety | Early Funding |
| Swelife | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
Partnered with Bachem Americas, Inc. for atopic dermatitis therapy.
- Nov 6, 2025
Strengthening collaboration with Zelmic AB.
Pharmability AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pharmability AB's valuation, stock price, and market status.
Is TIRmed Pharma a public or private company?
TIRmed Pharma is a private company.
What is the current stock price of TIRmed Pharma?
TIRmed Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is TIRmed Pharma worth (valuation)?
Valuation information for TIRmed Pharma is not publicly available.
Can I buy TIRmed Pharma stock?
TIRmed Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TIRmed Pharma's last funding round?
TIRmed Pharma's most recent funding round was Series A on April 9, 2025.
Who are the main investors in TIRmed Pharma?
Key investors in TIRmed Pharma include Sciety.
Will TIRmed Pharma IPO soon?
No public IPO plans have been announced for TIRmed Pharma.
How can I track TIRmed Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TIRmed Pharma's secondary market activity and sign up for updates.